Search Results - Huberle, C

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

    Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients by Jilg, S, Reidel, V, Müller-Thomas, C, König, J, Schauwecker, J, Höckendorf, U, Huberle, C, Gorka, O, Schmidt, B, Burgkart, R, Ruland, J, Kolb, H-J, Peschel, C, Oostendorp, R A J, Götze, K S, Jost, P J

    Published in Leukemia
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    34 AZACITIDINE DIRECTLY MODULATES FUNCTION OF MESENCHYMAL STROMAL CELLS TO ALTER BONE MARROW NICHE COMPOSTION AND SUPPRESS MALIGNANT HEMATOPOEITIC PROGENITORS IN MDS

    34 AZACITIDINE DIRECTLY MODULATES FUNCTION OF MESENCHYMAL STROMAL CELLS TO ALTER BONE MARROW NICHE COMPOSTION AND SUPPRESS MALIGNANT HEMATOPOEITIC PROGENITORS IN MDS by Huberle, C, Wenk, C, Witham, D, Garz, A.K, Pagel, C, Müller-Thomas, C, Kaur-Bollinger, P, Oostendorp, R, Peschel, C, Goetze, K.S

    Published in Leukemia research
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    27 BLOCKADE OF BCL-2 PROTEINS EFFICIENTLY INDUCES APOPTOSIS IN PROGENITOR CELLS OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS

    27 BLOCKADE OF BCL-2 PROTEINS EFFICIENTLY INDUCES APOPTOSIS IN PROGENITOR CELLS OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS by Jilg, S, Reidel, V, Mueller-Thomas, C, Koenig, J, Schauwecker, J, Burgkart, R, Hoeckendorf, U, Huberle, C, Gorka, O, Ruland, J, Kolb, H, Peschel, C, Oostendorp, R, Goetze, K, Jost, P

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    P-016 Resistance to apoptosis in high-risk myelodysplastic syndrome can be overcome by pro-apoptotic drug treatment using ABT-737

    P-016 Resistance to apoptosis in high-risk myelodysplastic syndrome can be overcome by pro-apoptotic drug treatment using ABT-737 by Jilg, S, König, J, Höckendorf, U, Schauwecker, J, Huberle, C, Müller-Thomas, C, Schmidt, B, Burgkart, R, Götze, K, Kolb, H.J, Peschel, C, Jost, P.J

    Published in Leukemia research
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

    Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia by Müller-Thomas, Catharina, Rudelius, Martina, Rondak, Ina-Christine, Haferlach, Torsten, Schanz, Julie, Huberle, Christina, Schmidt, Burkhard, Blaser, Rainer, Kremer, Marcus, Peschel, Christian, Germing, Ulrich, Platzbecker, Uwe, Götze, Katharina

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: